Treatment and care for young amphetamine-type stimulant users
Access Status
Authors
Date
2012Type
Metadata
Show full item recordCitation
Source Title
ISBN
School
Collection
Abstract
In the early to mid-2000s, researchers, policy-makers, and service providers began to respond to a dramatic increase in the prevalence of crystal methamphetamine use in the community (McKetin & McLaren 2004). The Australian media touted such trends as indicative of an 'epidemic' termed the 'ice age' (Carney 2006); however, more recent data indicate that rates of use may have declined. For example, an annual survey of Australian regular ecstasy users in 2007 found that 71 % of the sample had used any type of methamphetamine in the previous six months, compared to 54% in 2009 (Black et al 2008; Sindicich & Burns 2010). Despite this drop, methamphetamine continues to be one of the most commonly used illicit drugs among young people in our community (Cassar et al 2009; Sindicich & Burns 2010). In this chapter we investigate how service providers and practitioners can best respond to the particular needs of those young people whose use of amphetamine-type stimulants (ATS), particularly methamphetamine, has become dependent and problematic.
Related items
Showing items related by title, author, creator and subject.
-
McKetin, Rebecca; Degenhardt, L.; Shanahan, M.; Baker, A.; Lee, N.; Lubman, D. (2017)Aim and background. We estimated health service utilisation attributable to methamphetamine use, its national impact and examined other predictors of health service utilisation among dependent methamphetamine users. Method. ...
-
McKetin, Rebecca; Najman, J.; Baker, A.; Lubman, D.; Dawe, S.; Ali, R.; Lee, N.; Mattick, R.; Mamun, A. (2012)Aims: To evaluate the impact of community-based drug treatment on methamphetamine use using inverse probability of treatment-weighted (IPTW) estimators to derive treatment effects. Design: A longitudinal prospective cohort ...
-
Dwyer, Robyn; Moore, David (2013)Over the last decade in Australia, methamphetamine has come to be seen as a significant issue for drug research, policy and practice. Concerns have been expressed over its potency, the increasing prevalence of its use and ...